Engineering BCMA-CAR T cells to overcome CD19-negative relapse in B cell non-Hodgkin lymphomas

被引：0
|
作者：
Antonana-Vildosola, A. [1 ]
Perez-Amill, L. [1 ]
Sune, G. [1 ]
Castella, M. [1 ]
Najjar, A. [2 ]
Urbano, A. [1 ,3 ]
Martin-Antonio, B. [1 ,3 ]
机构：
[1] IDIBAPS, Barcelona, Spain
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Josep Carreras Leukemia Res Inst, Barcelona, Spain
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P164
引用
收藏
页码：A67 / A68
页数：2
相关论文
共 50 条
  • [31] Proposals of B cells standard immunophenotyping in mature B cell non-Hodgkin lymphomas
    Podstawka, Urszula
    Szczepanska, Izabella
    Kopec-Szlezak, Joanna
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 33 (04) : 202 - 207
  • [32] Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
    Jackson, Zachary
    Roe, Anne
    Sharma, Ashish Arunkumar
    Lopes, Filipa Blasco Tavares Pereira
    Talla, Aarthi
    Kleinsorge-Block, Sarah
    Zamborsky, Kayla
    Schiavone, Jennifer
    Manjappa, Shivaprasad
    Schauner, Robert
    Lee, Grace
    Liu, Ruifu
    Caimi, Paolo F.
    Xiong, Ying
    Krueger, Winfried
    Worden, Andrew
    Kadan, Mike
    Schneider, Dina
    Orentas, Rimas
    Dropulic, Boro
    Sekaly, Rafick-Pierre
    de Lima, Marcos
    Wald, David N.
    Reese, Jane S.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [33] CD8 expression in B-cell non-Hodgkin's lymphomas
    Carulli, Giovanni
    Cannizzo, Elisa
    Marini, Alessandra
    Rossi, Angela
    Baccelli, Emanuela
    Petrini, Mario
    ANNALS OF HEMATOLOGY, 2008, 87 (07) : 577 - 579
  • [34] ARI0003: Co-transduced CD19/BCMA dual-targeting CAR-T cells for the treatment of non-Hodgkin lymphoma
    Bachiller, Mireia
    Barcelo-Genestar, Nina
    Rodriguez-Garcia, Alba
    Alserawan, Leticia
    Dobano-Lopez, Celia
    Gimenez-Alejandre, Marta
    Castellsague, Joan
    Colell, Salut
    Otero-Mateo, Marc
    Antonana-Vildosola, Asier
    Espanol-Rego, Marta
    Ferruz, Noelia
    Pascal, Mariona
    Martin-Antonio, Beatriz
    Anguela, Xavier M.
    Fillat, Cristina
    Olesti, Eulalia
    Calvo, Gonzalo
    Juan, Manel
    Delgado, Julio
    Perez-Galan, Patricia
    Urbano-Ispizua, Alvaro
    Guedan, Sonia
    MOLECULAR THERAPY, 2025, 33 (01) : 317 - 335
  • [35] CD8 expression in B-cell non-Hodgkin’s lymphomas
    Giovanni Carulli
    Elisa Cannizzo
    Alessandra Marini
    Angela Rossi
    Emanuela Baccelli
    Mario Petrini
    Annals of Hematology, 2008, 87
  • [36] Postinfusion PD-1+CD8+CAR T cells identify patients responsive to CD19 CAR T-cell therapy in non-Hodgkin lymphoma
    Denlinger, Nathan
    Song, No-Joon
    Zhang, Xiaoli
    Jeon, Hyeongseon
    Peterson, Chelsea
    Wang, Yi
    Reynolds, Kelsi
    Bolz, Robert M.
    Miao, Jessica
    Song, Chunhua
    Wu, Dayong
    Chan, Wing Keung
    Bezerra, Evandro
    Epperla, Narendranath
    Voorhees, Timothy J.
    Brammer, Jonathan
    Kittai, Adam S.
    Bond, David A.
    Sawalha, Yazeed
    Sigmund, Audrey
    Reneau, John C.
    Rubinstein, Mark P.
    Hanel, Walter
    Christian, Beth
    Baiocchi, Robert A.
    Maddocks, Kami
    Alinari, Lapo
    Vasu, Sumithira
    de Lima, Marcos
    Chung, Dongjun
    Jaglowski, Samantha
    Li, Zihai
    Huang, Xiaopei
    Yang, Yiping
    BLOOD ADVANCES, 2024, 8 (12) : 3140 - 3153
  • [37] CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia
    Chong, Elise A.
    Levine, Bruce L.
    Grupp, Stephan A.
    Davis, Megan
    Siegel, Don L.
    Maude, Shannon L.
    Gladney, Whitney Lynn
    Frey, Noelle V.
    Porter, David L.
    June, Carl H.
    Schuster, Stephen J.
    BLOOD, 2018, 132
  • [38] Outcomes in Aggressive B-Cell Non-Hodgkin Lymphomas with Anti-CD19 CAR T-Cell (CTL019) Products Not Meeting Commercial Release Specifications
    Chong, Elise A.
    Gerson, James N.
    Landsburg, Daniel J.
    Nasta, Sunita Dwivedy
    Svoboda, Jakub
    Porter, David L.
    Dengel, Karen
    Siegel, Don L.
    Gilmore, Joan
    Barta, Stefan K.
    Levine, Bruce L.
    June, Carl H.
    Schuster, Stephen J.
    BLOOD, 2019, 134
  • [39] CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Sauter, Craig S.
    Senechal, Brigitte
    Riviere, Isabelle
    Ni, Ai
    Bernal, Yvette
    Wang, Xiuyan
    Purdon, Terence
    Hall, Malloury
    Singh, Ashvin N.
    Szenes, Victoria Z.
    Yoo, Sarah
    Dogan, Ahmet
    Wang, Yongzeng
    Moskowitz, Craig H.
    Giralt, Sergio
    Matasar, Matthew J.
    Perales, Miguel-Angel
    Curran, Kevin J.
    Park, Jae
    Sadelain, Michel
    Brentjens, Renier J.
    BLOOD, 2019, 134 (07) : 626 - 635
  • [40] Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based model
    Diandian Ba
    Hongzhe Li
    Rongrong Liu
    Ping Zhang
    Yongmin Tang
    Apoptosis, 2023, 28 : 1534 - 1545
12345